– UAE, Abu Dhabi – NMC Health plc (LSE:NMC), the leading integrated healthcare provider operating across the United Arab Emirates today announces a number of changes to its Board all effective on 28 June 2017.
Resignation of Directors
Mr Keyur Nagori and Mr Binay Shetty, Non-Executive Directors of NMC Health Plc representing the interests of the principal shareholders in accordance with the Relationship Agreement with the Company, have decided to step down from the Board.
Keyur Nagori has been a Non-Executive Director of the Company since 26 June 2014. Prior to that was an Alternate Director to the Company’s previous Director, H.E. Saeed Bin Butti, from 27 June 2013 to 24 February 2014 and has resigned from the Board for personal family reasons.
Mr Binay Shetty was an Executive Director of the Company from 26 June 2014 until 31 December 2014, before which he was a member of the Senior Management Team since before the IPO of the Company in April 2012. Since 1 January 2015 Binay Shetty has been a Non-Executive Director of the Company and has now decided that it is an appropriate time for him to step down from the Board in order to focus on his other work commitments.
Appointment of Directors
NMC announces the appointment of Mr Khalifa Bin Butti, who rejoins the Board, and Mr Hani Buttikhi as additional Directors of the Company.
Khalifa Bin Butti is an international businessman and investor. He currently holds several roles in UK and Middle East firms including Chairman of KBBO Group, Bin Butti International Holding, Infinite Investments, BHS LLC and One Financial Markets. He is also Executive Vice Chairman of Centurion Investments. Khalifa Bin Butti is re-joining the NMC Health plc board in his previous role as Executive Vice Chairman.
Hani Buttikhi was Head of Syndicate, Investment Banking for SHUAA Capital psc Dubai from 2006 to 2014. In June 2014 Hani Buttikhi was appointed as an advisor to the Chairman of KBBO Group and, in addition, since June 2015 has been Chief Investment Officer for Centurion Investments. Hani Buttikhi is a Director of a number of companies including Travelex Group, Hakkasan Group and One Financial Markets. Hani joins the Board as an Executive Director.
Khalifa Bin Butti and Hani Buttikhi join the board having been nominated by the Company’s principal shareholders pursuant to the terms of the Relationship Agreement between the principal shareholders and the Company.
Mark Tompkins, Joint Non-Executive Chairman of NMC Health commented: ‘The Board would like to thank Keyur for his contribution as a Director of the Company over the last four years, and particularly during the last 2 years of significant acquisitive growth. Keyur leaves the board with our very best wishes for the future.
Binay Shetty has been with the NMC Group for over 12 years, in the role of Chief Operating Officer prior to IPO until 31 December 2014, since when he has remained on the Board as a Non-Executive Director. The Board are very grateful for Binay’s significant contribution to the growth of the Group as both a Senior Executive and a Non-Executive Director and give him our very best wishes for the future.
We also welcome Khalifa Bin Butti back to the Board, and Hani Buttikhi on his appointment as a Director and look forward to working with them both as the Board continues to support management in the execution of the Group’s strategic growth plan’
About NMC Health
The NMC group is the leading private sector healthcare operator in the United Arab Emirates, with a nation-wide network of hospitals and operations in the country since 1975. The Group currently operates or manages eight hospitals, two day-care patient centres, nine medical centres and fifteen pharmacies. In addition, the Group owns and operates Clinica Eugin in Barcelona, Spain – one of the leading fertility treatment centres globally. NMC also owns a 51 per cent. shareholding in Fakih IVF Group, the Middle East market leader for in-vitro fertilisation (“IVF”) services. Moreover, NMC also owns and operates Americare Group, the leading home care provider in the UAE as well as ProVita, the pioneering provider of long-term medical care, also in the UAE. The enlarged company received almost 4.3 million patients in 2016. The Group is also a leading UAE supplier of products and consumables across several key market segments, with the major contribution coming from healthcare related products. The Group reported revenues of US$1,220.8 million for the year ended 31 December 2016.
In April 2012 NMC was listed on the Premium Segment of the London Stock Exchange. NMC is a constituent of the FTSE 250 Index.
For more information : http://www.nmc.ae
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.